Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...

Kimbell Royalty offers stability with robust cash flow, growth from acquisitions, a strong balance sheet, and a 28% upside ...

Worthington Enterprises Inc. (NYSE: WOR), a designer and manufacturer of market-leading brands that improve everyday life by elevating spaces and experiences ...